Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why didn't PTSC know

''Between 2006-2008 TPL expands Alliacense and added 3 patent portfolios to the MMP it was previously licensing and began marketing & commingling its efforts for all 4 portfolios''

I saw this and made several comments about hoping they were creating a new potfolio to enhance the MMP in someway, they did file some extending patents I thought, and expected this cross-licensing to benifit us all as 50/50 partners.

but guess not

emit...

Share
New Message
Please login to post a reply